Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.

By E. Mayer, D. Jenkins, J. Lindner, A. D’Armini, J. Kloek, B. Meyns, L. Ilkjaer, W. Klepetko, M. Delcroix, I. Lang and 3 more. Journal of Thoracic and Cardiovascular Surgery, 2011

700 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/f0cce65de1c207affcf27c0498bf2e648acb7bd9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

Citations in the corpus

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. (2013, background): “Prolonged activated partial-thromboplastin time 2 (2) 8 (5)”
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019, background): “General criteria include pre-operative New York Heart Association (NYHA) functional class and the surgical accessibility of thrombi in the main, lobar, or segmental pulmonary arteries.(462) Advanced age per se is no contraindication for surgery.”
[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. (2014, positive): “7% in expert centres.(398) The majority of patients experience substantial relief from symptoms and near-normalization of haemodynamics.”
ESC Guidelines on the diagnosis and management of acute pulmonary embolism (2014, background): “7% in expert centres.(398) The majority of patients experience substantial relief from symptoms and near-normalization of haemodynamics.”